Who owns BioMarin Pharmaceutical?

Key details on BioMarin Pharmaceutical (Ticker: BMRN)

Who owns BioMarin Pharmaceutical?

Is BMRN a good stock to own? Find out who bought BioMarin Pharmaceutical, who sold BioMarin Pharmaceutical (BMRN) stock, and who holds a large position in BioMarin Pharmaceutical.

Fund Name Number of Shares Share Valuation As Of
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 38.66M $38.27M March 31, 2015
Capital Research Global Investors^ 19.26M $1.87B Dec. 31, 2014
FMR 12.58M $907.83M Sept. 30, 2014
Sands Capital Management 12.18M $1.10B Dec. 31, 2014
Vanguard 8.85M $799.86M Dec. 31, 2014
PRIMECAP Management Company 8.02M $724.69M Dec. 31, 2014
Jennison Associates 5.52M $688.02M March 31, 2015
WINSLOW CAPITAL MANAGEMENT INC /MN 4.82M $328.84M March 31, 2014
STATE STREET CORPORATION 3.96M $285.63M Sept. 30, 2014
Baker Bros. Advisors 3.71M $335.74M Dec. 31, 2014
Capital World Investors^ 3.68M $205.21M June 30, 2013
Altrinsic Global Advisors 3.59M $144.55M Sept. 30, 2012
BlackRock Institutional Trust Company, N.A. 3.53M $318.67M Dec. 31, 2014
Inves 3.19M $128.31M Sept. 30, 2012
Columbia Wanger Asset Management 3.10M $193.32M March 31, 2013
Manning & Napier Advisors 3.04M $96.76M Sept. 30, 2011

Who sold BioMarin Pharmaceutical?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company March 31, 2014 3.47M $260.08M
Cramer Rosenthal McGlynn Sept. 30, 2011 3.92M $125.08M
Sectoral Asset Management Sept. 30, 2011 3.54M $112.96M
T. Rowe Price Associates Aug. 12, 2011 5.07M $137.98M
Munder Capital Management June 30, 2011 3.00M $81.54M
OrbiMed Advisors Dec. 31, 2010 3.41M $91.82M